228 related articles for article (PubMed ID: 21333752)
1. Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agent.
Makino A; Harada H; Okada T; Kimura H; Amano H; Saji H; Hiraoka M; Kimura S
Nanomedicine; 2011 Oct; 7(5):638-46. PubMed ID: 21333752
[TBL] [Abstract][Full Text] [Related]
2. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
4. Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
Boros E; Polasek M; Zhang Z; Caravan P
J Am Chem Soc; 2012 Dec; 134(48):19858-68. PubMed ID: 23157602
[TBL] [Abstract][Full Text] [Related]
5. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
6. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
7. A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent.
Wang L; Zhu X; Tang X; Wu C; Zhou Z; Sun C; Deng SL; Ai H; Gao J
Chem Commun (Camb); 2015 Mar; 51(21):4390-3. PubMed ID: 25676633
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the water proton relaxivity by trapping Gd3+ complexes in nanovesicles.
Fries PH; Belorizky E
J Chem Phys; 2010 Jul; 133(2):024504. PubMed ID: 20632760
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
[TBL] [Abstract][Full Text] [Related]
10. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
Shiraishi K; Kawano K; Maitani Y; Yokoyama M
J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
[TBL] [Abstract][Full Text] [Related]
11. Nano assembly and encapsulation; a versatile platform for slowing the rotation of polyanionic Gd(3+) -based MRI contrast agents.
Farashishiko A; Chacón KN; Blackburn NJ; Woods M
Contrast Media Mol Imaging; 2016; 11(2):154-9. PubMed ID: 26708733
[TBL] [Abstract][Full Text] [Related]
12. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
13. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
14. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
15. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes.
Martinelli J; Fekete M; Tei L; Botta M
Chem Commun (Camb); 2011 Mar; 47(11):3144-6. PubMed ID: 21270985
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
17. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin.
Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P
Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282
[TBL] [Abstract][Full Text] [Related]
18. Engineered Paramagnetic Graphene Quantum Dots with Enhanced Relaxivity for Tumor Imaging.
Yang Y; Chen S; Li H; Yuan Y; Zhang Z; Xie J; Hwang DW; Zhang A; Liu M; Zhou X
Nano Lett; 2019 Jan; 19(1):441-448. PubMed ID: 30560672
[TBL] [Abstract][Full Text] [Related]
19. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging.
Ye Z; Wu X; Tan M; Jesberger J; Grisworld M; Lu ZR
Contrast Media Mol Imaging; 2013; 8(3):220-8. PubMed ID: 23606425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
